Rheumatology
Conference Coverage
Be alert for dermatomyositis without muscle disease
Be alert for amyotrophic dermatomyositis in patients with rash where lupus might be considered.
News from the FDA/CDC
FDA approves biosimilar adalimumab
There are “no clinically meaningful differences” between Amgen’s biosimilar adalimumab (Amjevita) and AbbVie’s branded product Humira, the Food...
Conference Coverage
VIDEO: Consider immunogenicity when choosing biologics
Conference Coverage
VIDEO: Consider chikungunya for unexplained seronegative arthritis
LAS VEGAS – A patient who presents with weeks of unexplained arthralgia and perhaps arthritis and a negative autoimmune panel deserves...
News
Try non-TNF biologics for RA if anti-TNF fails
News
No difference in serious infection rates between SLE treatments
News
Pain starting in knee later arises in other joints
Key clinical point:People with frequently painful knees often develop pain in joints outside the knee, and the sites vary from person to person....
News
United States an expensive place for knee, hip replacement
News
Lowering LDL-C yields usual benefits in rheumatoid arthritis
Key clinical point: Lowering LDL cholesterol yields the same cardiovascular benefits in rheumatoid arthritis patients as in the general population...
News
Tailored exercise boosts physical function for knee OA patients with comorbidities
Key clinical point: Adults with knee osteoarthritis and at least one comorbid condition had significant improvement in physical function after a...
News
Biosimilar version of etanercept gains FDA approval
A biosimilar of etanercept received clearance for marketing from the FDA for all of the inflammatory disease indications held by the reference...